Effectiveness and efficiency of the meningococcal C toddler vaccination and of introducing meningococcal ACWY toddler and adolescent vaccination in Germany
Günther, F.; Piechotta, V.; Wichmann, O.; Harder, T.; Dalpke, A.; Sandmann, F. G.
Show abstract
BackgroundIn Germany, primary vaccination against invasive meningococcal disease (IMD) in young children is recommended against serotype C (MenC) since 2005 and B (MenB) since 2024. Because of changes in the epidemiology of serogroups C and Y, we re-evaluated the MenC toddler vaccination, also considering scenarios of MenACWY vaccination. MethodsWe used a dynamic-transmission model of meningococcal carriage calibrated to national surveillance data for 10-year simulations. We compared MenC vaccination in toddlers aged 12-23 month with scenarios of (i) no MenC/MenACWY vaccination, (ii) MenACWY toddler vaccination, (iii) MenACWY primary adolescent vaccination, and (iv) combined MenACWY toddler plus adolescent booster vaccination. We compared prevented IMD cases, sequelae and deaths. In sensitivity analyses we varied key assumptions like adolescent vaccine uptake. ResultsThe expected annual mean of 243 (95%-uncertainty interval: 220-258) IMD cases with the MenC toddler vaccination increased by 2.9 (2.2-3.7) cases without MenC vaccination, including 1.2 (0.9-1.5) sequelae and 0.2 (0.2-0.3) deaths. Conversely, IMD cases were reduced by 2.4 (1.7-2.9), 1.7 (0.9-2.6), or 6.8 (5.7-7.6), with MenACWY toddler, primary adolescent, or combined toddler and adolescent vaccination, respectively. Preventing one IMD case required 210,000 (170,000-280,000) MenC or 120,000 (98,000-140,000) MenACWY toddler, 99,000 (84,000-110,000) MenACWY toddler and adolescent, and 72,000 (61,000-86,000) MenACWY primary adolescent vaccinations. Effectiveness of adolescent vaccination increased near-linearly with uptake. ConclusionsContinuing toddler vaccination with MenACWY (or MenC) keeps the IMD burden slightly lower than without toddler vaccination. Yet, introducing MenACWY primary adolescent vaccination was the most efficient scenario, pending sufficient uptake. Serotype carriage requires up-to-date monitoring.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022 96%
- Modelling optimal vaccination strategies against Covid-19 in a context of Gamma variant predominance in Brazil 94%
- Effectiveness of second booster compared to first booster and protection conferred by previous SARS CoV-2 infection against symptomatic Omicron BA.2 and BA.4/5 in France 94%
Similar papers in this journal
- Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection in the Netherlands, September to December 2022 94%
- Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands 93%
- The risk of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data 93%
Similar papers in this journal
- Non-pharmaceutical interventions and vaccinating school children required to contain SARS-CoV-2 Delta variant outbreaks in Australia: a modelling analysis 94%
- Projecting vaccine demand and impact for emerging zoonotic pathogens 94%
- An assessment of the vaccination of school-aged children in England 93%
Similar papers in this journal
- Predicting the epidemiological effects in the United Kingdom of moving from PCV13 to PCV15 in the routine pediatric 1+1 vaccination schedule 94%
- Modeling the impact of COVID-19 vaccination in Lebanon: A call to speed-up vaccine roll out 93%
- COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022 93%
Similar papers in this journal
- Protection of COVID-19 vaccination and previous infection against Omicron BA.1 and Delta SARS-CoV-2 infections, the Netherlands, 22 November 2021- 19 January 2022 95%
- Optimal age targeting for pneumococcal vaccination in older adults; a modelling study 93%
- The impact of vaccination on preventing long COVID in the Omicron era: a systematic review and meta-analysis 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.